Monro (NASDAQ:MNRO) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.55 by 12.73 percent. This is a 58.97 percent increase over earnings of $0.39 per share from the same period last year. The company reported quarterly sales of $347.70 million which beat the analyst consensus estimate of $338.43 million by 2.74 percent. This is a 20.48 percent increase over sales of $288.59 million the same period last year.
Monro Q2 EPS $0.62 Beats $0.55 Estimate, Sales $347.70M Beat $338.43M Estimate
Monro (NASDAQ:MNRO) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.55 by 12.73 percent. This is a 58.97 percent increase over earnings of $0.39 per share from the same
Related Posts
SCYNEXIS Wins $225K Department Of Veteran Affairs Contract
https://sam.gov/opp/f098350702474f5085fbb424c6a7661e/view
MoneyLion Earnings Perspective: Return On Capital Employed
MoneyLion (NYSE:ML) brought in sales totaling $87.34 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 131.16%, resulting in a loss of $23.07 million.
Biogen’s New Alzheimer’s Drug Turned Away By Veterans Affairs
The Department of Veterans Affairs (VA) has decided not to include the new Alzheimer’s drug developed by Biogen Inc (NASDAQ:BIIB)…